Acadia Pharmaceuticals Inc. (ACAD) short interest & options flow
NASDAQACAD short interest fell 29.5% in one week to 4.5% of float, now at 7.6M shares as of October 16, with cost to borrow easing to 0.35% and availability surging to 2,473% of short interest.
- Market cap
- $3.70B
- Next earnings
- 25 Feb 2027
Key data as of 5 Nov 2026
Latest signals on ACAD
- Short Interest
ACAD short interest fell 29.5% in one week to 4.5% of float, now at 7.6M shares as of October 16, with cost to borrow easing to 0.35% and availability surging to 2,473% of short interest.
4 Short Interest updates in 30 days
- Analyst
ACAD UBS downgrades to Neutral, cuts price target 53% to $23 from $49.
ACAD news and analysis
RSSNo long-form analysis yet for ACAD. Pulse alerts and the live data picture are available on ORTEX.
Open ACAD on ORTEX →Want the live picture for ACAD?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ACAD — free to start on ORTEX.
Sign up for free →Open ACAD on ORTEX